特朗普政府的目标是误导性的药物广告,推动更明确地披露副作用。 Trump administration targets misleading drug ads, pushing for clearer disclosure of side effects.

特朗普政府正打击直接对消费者的处方药广告,目的是提高透明度和准确性。 The Trump administration is cracking down on direct-to-consumer prescription drug ads, aiming to boost transparency and accuracy. 美国食品和药物管理局和联邦贸易委员会被指示审查和加强法规,向具有误导性广告的公司发出警告和停止和放弃信件. The FDA and FTC are instructed to review and tighten regulations, issuing warnings and cease-and-desist letters to companies with misleading ads. 此举的目标是建立138亿美元的行业,目的是确保广告披露所有副作用,兼顾风险和效益,有可能改变推广药物的方式。 This move targets a $13.8 billion industry, aiming to ensure ads disclose all side effects and balance risks with benefits, potentially reshaping how medications are promoted.